Braveheart Bio, Inc. · NASDAQ:BRVE

Braveheart Bio, Inc. insider trades

Braveheart Bio, Inc.'s insiders made 13 buys and 0 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

DateInsiderTradeSharesPriceFiling
Aug 7, 2026OrbiMed Genesis GP LLCBuy1,666,667US$18.00Form 4
Aug 7, 2026OrbiMed Genesis GP LLCBuy273,333US$18.00Form 4
Aug 7, 2026Chimovits ErezBuy1,666,667US$18.00Form 4
Aug 7, 2026Chimovits ErezBuy273,333US$18.00Form 4
Aug 7, 2026Andreessen Marc LBuy1,100,000US$18.00Form 4
Aug 7, 2026Forbion Growth Opportunities Fund III Cooperatief U.A.Buy1,920,000US$18.00Form 4
Aug 7, 2026Forbion Growth Opportunities Fund III Cooperatief U.A.Buy1,680,000US$18.00Form 4
Aug 7, 2026Lubner David CharlesBuy55,555US$18.00Form 4
Aug 7, 2026Travis MurdochBuy83,333US$18.00Form 4
Aug 7, 2026Anderson Michele A.Buy1,111US$18.00Form 4

Braveheart Bio, Inc. shareholders